Patent classifications
A61K36/328
<i>Commiphora molmol </i>(myrrh) resin extracts and uses thereof for wound healing and treatment and prevention of mucositis and other diseases
Provided herein are compositions comprising acidic extracts of Commiphora molmol (Myrrh) resin for the treatment and prevention of oral mucositis, mucosal infections, topical inflammations, bed sores, decubitis, inflammations of the gastrointestinal tract, canker sores, dental mouth lining ulcers, Behcet disease, and for acute and chronic wound healing. Also provided are methods for producing the disclosed compositions.
Herbal pharmaceutical compositions for ano-rectal diseases and method of preparation thereof
Herbal pharmaceutical compositions for the treatment of ano-rectal diseases are provided. The compositions include C. molmol, Gardenia spp, T. erecta, M. ferrea, activated charcoal, probiotic, neem and/or curcumin, cloves, isabgol, pharmaceutical excipients, and optionally a therapeutic agent. The compositions possess properties to control inflammation by lowering levels of inflammatory cytokines and matrix metalloproteinases, prevent capillary bleeding and fragility in mammals, particularly human beings and have wound healing properties.
Herbal pharmaceutical compositions for ano-rectal diseases and method of preparation thereof
Herbal pharmaceutical compositions for the treatment of ano-rectal diseases are provided. The compositions include C. molmol, Gardenia spp, T. erecta, M. ferrea, activated charcoal, probiotic, neem and/or curcumin, cloves, isabgol, pharmaceutical excipients, and optionally a therapeutic agent. The compositions possess properties to control inflammation by lowering levels of inflammatory cytokines and matrix metalloproteinases, prevent capillary bleeding and fragility in mammals, particularly human beings and have wound healing properties.
Herbal pharmaceutical compositions for ano-rectal diseases and method of preparation thereof
Herbal pharmaceutical compositions for the treatment of ano-rectal diseases are provided. The compositions include C. molmol, Gardenia spp, T. erecta, M. ferrea, activated charcoal, probiotic, neem and/or curcumin, cloves, isabgol, pharmaceutical excipients, and optionally a therapeutic agent. The compositions possess properties to control inflammation by lowering levels of inflammatory cytokines and matrix metalloproteinases, prevent capillary bleeding and fragility in mammals, particularly human beings and have wound healing properties.
NATURAL PRODUCT COMPOSITIONS FOR MANAGEMENT OF CHOLESTEROL LEVELS
A composition includes Commiphora mukul extract, Camellia sinensis extract, and Trigonella foenum-graecum extract. The composition may further include Allium sativum extract, Zingiber officinale extract, and Cinnamomum verum extract. The composition may include Commiphora mukul extract at about 24%-36% by weight of the total composition, the Allium sativum extract at about 20%-30% by weight of the total composition, the Camellia sinensis extract at about 12%-18% by weight of the total composition, the Trigonella foenum-graecum extract at about 12%-18% by weight of the total composition, the Zingiber officinale extract at about 8%-12% by weight of the total composition, and the Cinnamomum verum extract at about 4%-6% by weight of the total composition. The disclosure further provides methods of treating hyperlipidemia using the disclosed compositions.
NATURAL PRODUCT COMPOSITIONS FOR MANAGEMENT OF CHOLESTEROL LEVELS
A composition includes Commiphora mukul extract, Camellia sinensis extract, and Trigonella foenum-graecum extract. The composition may further include Allium sativum extract, Zingiber officinale extract, and Cinnamomum verum extract. The composition may include Commiphora mukul extract at about 24%-36% by weight of the total composition, the Allium sativum extract at about 20%-30% by weight of the total composition, the Camellia sinensis extract at about 12%-18% by weight of the total composition, the Trigonella foenum-graecum extract at about 12%-18% by weight of the total composition, the Zingiber officinale extract at about 8%-12% by weight of the total composition, and the Cinnamomum verum extract at about 4%-6% by weight of the total composition. The disclosure further provides methods of treating hyperlipidemia using the disclosed compositions.
NATURAL PRODUCT COMPOSITIONS FOR MANAGEMENT OF CHOLESTEROL LEVELS
A composition includes Commiphora mukul extract, Camellia sinensis extract, and Trigonella foenum-graecum extract. The composition may further include Allium sativum extract, Zingiber officinale extract, and Cinnamomum verum extract. The composition may include Commiphora mukul extract at about 24%-36% by weight of the total composition, the Allium sativum extract at about 20%-30% by weight of the total composition, the Camellia sinensis extract at about 12%-18% by weight of the total composition, the Trigonella foenum-graecum extract at about 12%-18% by weight of the total composition, the Zingiber officinale extract at about 8%-12% by weight of the total composition, and the Cinnamomum verum extract at about 4%-6% by weight of the total composition. The disclosure further provides methods of treating hyperlipidemia using the disclosed compositions.
Methods for Treating Neurological Disorders Using Nutrient Compositions
Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.
Methods for Treating Neurological Disorders Using Nutrient Compositions
Nutrient compositions comprising botanical extracts and methods of their use for treating, inter alia, autism or apraxia and/or ameliorating one or more symptoms thereof are disclosed. The use of such compositions for enhancing cognitive function and/or one or more aspects thereof, or for treating stroke or seizures and/or ameliorating one or more symptoms thereof are also disclosed.
COMMIPHORA MOLMOL (MYRRH) RESIN EXTRACTS AND USES THEREOF FOR WOUND HEALING AND TREATMENT AND PREVENTION OF MUCOSITIS AND OTHER DISEASES
Provided herein are compositions comprising acidic extracts of Commiphora molmol (Myrrh) resin for the treatment and prevention of oral mucositis, mucosal infections, topical inflammations, bed sores, decubitis, inflammations of the gastrointestinal tract, canker sores, dental mouth lining ulcers, Behcet disease, and for acute and chronic wound healing. Also provided are methods for producing the disclosed compositions.